Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 2/3 × Has announcements × nilotinib × Clear all

Phase

Phase 2 3 Phase 1 2 Phase 3 1

Sponsor

Interventions

umbralisib 1 ublituximab 1 relatlimab 1 pembrolizumab 1 palbociclib 1 inavolisib 1 imetelstat 1 Pemetrexed 1 Nivolumab 1 GRN163L peptide 1 Fulvestrant 1 Emapalumab 1 Cisplatin 1 Bendamustine Hydrochloride 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡